
Journal of labelled compounds and radiopharmaceuticals p. 363 - 376 (1998)
Update date:2022-08-03
Topics:
Waterhouse, Rikki N.
Gotsick, J. Timothy
Kabalka, George W.
Goodman, Mark M.
O'Brien
[123I]-8-[4-[2-(5-Iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3,8- triazaspiro[4.5]-decan-4-one (1) has been synthesized as a potential ligand for dopamine D2 receptors. This new compound proved to be moderate in lipophilicity (log
View MoreNanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
Lianyungang Ningkang Chemical Co., Ltd
Contact:.+86-518-88588008
Address:http://www.chemnk.com
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Weihao Chemtech (ChangZhou) Co., Ltd.(expird)
Contact:051989185693
Address:NO 217 huangshan Rd ,Changzhou
Doi:10.1016/S0040-4020(01)96351-3
(1968)Doi:10.1002/1521-3765(20001215)6:24<4558::AID-CHEM4558>3.0.CO;2-6
(2000)Doi:10.1002/hlca.19840670720
(1984)Doi:10.1016/S0960-894X(98)00194-2
(1998)Doi:10.1016/S0040-4020(98)00467-0
(1998)Doi:10.1055/s-1998-1819
(1998)